Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Analysts ‘disappointed’ by Sanofi guidance

February 6, 2014 Sales and Marketing Aubagio, Plavix, Sanofi, q4, sales

Sanofi has announced a mixed bag for its full year results as analysts have questioned why its forecasts for the …
News

Gilead to allow cheaper generics of new hep C drug

February 6, 2014 Manufacturing and Production, Sales and Marketing Gilead, India, generics, hep C, s&m, sofosbuvir, sovaldi

Gilead has announced the unusual step of allowing its new and highly expensive hepatitis C pill to be sold as …
News

Nicox makes two appointments

February 6, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NicOx, nguyen, nicolas

French pharma firm Nicox has hired Evelyne Nguyen to be its chief financial officer and Stéphane Nicolas joins its executive …
Appointment

GSK to make ‘fundamental changes’

February 6, 2014 Sales and Marketing China, GSK, Tafinlar, Witty, q4, results

GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …
News

Globe faces cancer ‘tidal wave’

February 5, 2014 Research and Development, Sales and Marketing Cancer, WHO, globe, world cancer report

The World Health Organisation has warned of a ‘tidal wave’ of cancer cases which it says will sweep across the …
News

Drug giants team up for Alzheimer’s

February 5, 2014 Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer

The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …
News

Laird chief executive takes up key innovation role





February 5, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing david lockwood, laird

David Lockwood OBE has been appointed to an influential business innovation role in the UK as non-executive chair of the …
Appointment

Three new entries to Cancer Drugs Fund

February 5, 2014 Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo

Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …
News

Cancer Research UK turns to gamification with app

February 4, 2014 Medical Communications, Sales and Marketing CRUK, Cancer, Gamification, genes in space

Cancer Research UK has launched a new citizen science game aimed at helping its scientists discover new cures for cancer. …
News

Pfizer breast cancer drug shows promise

February 4, 2014 Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib

Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial.  The pill was administered …
News

Biogen Idec’s MS drug gets European approval

February 4, 2014 Manufacturing and Production, Sales and Marketing Aubagio, Biogen IDEC, EU, MS, gilenya, tecdifera

Biogen Idec’s oral multiple sclerosis drug Tecfidera has won approval in Europe as a first-line treatment for people with relapsing-remitting …
News

AstraZeneca ‘simplifies decision-making’

February 4, 2014 Sales and Marketing AstraZeneca, BMS, Byetta, Forxiga, Onglyza, diabetes

AstraZeneca has completed its $4.3 billion acquisition of Bristol-Myers Squibb’s diabetes business, giving the company control over several big-name brands …
News

Sir Michael Parkinson criticises NICE

February 4, 2014 Medical Communications, Sales and Marketing Astellas, NHS, NICE, Xtandi, parkinson, prostate

TV host Sir Michael Parkinson has told NICE that it must lift the restrictions imposed on Astellas’ new prostate cancer …
News

Sartorius hires laboratory manager

February 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael Melingo, satorius

Lab and technology firm Sartorius has appointed Michael Melingo to be its laboratory manager. Melingo is to succeed Dominique Baly …
Appointment

Roche: NICE guidance ‘perverse’

February 4, 2014 Sales and Marketing NHS, NICE, NSCLC, Roche, Tarceva

Roche has poured scorn on NICE’s ‘perverse’ recommendation that its EGFR-TK inhibitor Tarceva should no longer be given to NHS …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026